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Purpose: This study analyzed the clinical and morphologic outcomes of endovascular treatment of ruptured isolated iliac
artery aneurysms (RIIAA) at midterm follow-up.
Methods: Eleven patients with RIIAA (1 woman, 10 men; mean age, 73 years; mean IIAA diameter, 69.1 mm) were
identified in a single-center database of patients who underwent endovascular aortoiliac aneurysm repair between April
2001 and December 2009. Devices inserted included 9 leg endografts in 7 patients (Excluder, n  7; Zenith, n  2), 3
bifurcated stent grafts in 3 patients (Excluder), and 1 aortouniiliac stent graft in 1 patient (Zenith). Endovascular
occlusion of the internal iliac artery or its branches was performed in all cases by coils (n 10) or Amplatzer occluder plug
(n 1). Immediately after endovascular aneurysm exclusion, a computed tomography (CT) angiography was obtained in
nine patients. Except for this adjunct postimplantation CT scanning, the imaging follow-up was the same as for
nonruptured aortoiliac aneurysms at 3, 6, and 12 months and annually thereafter.
Results:Mean delay from hospital admission to intervention was 78.5 minutes. Mean intervention time was 150 minutes.
The assisted primary technical success rate was 100%. Median lengths of stay were 2 days in the intensive care unit and 13
days in the hospital. Abdominal compartment syndrome developed in three patients who received open abdomen
treatment. The 30-day mortality was 18%. The mean follow-up was 23 months (range, 0-69 months). There were no late
deaths during the follow-up. There was no need for late surgical conversion. Aneurysm sac shrinkage (defined as>5 mm)
was recorded in five patients, whereas the sac diameter remained stable in four. There was no patient with aneurysm sac
growth. Additional stent graft insertion as the only secondary intervention for a type Ib leak was performed. Type II
endoleaks (primary and secondary) were found in 36% and secondary Ib in 9% of the patients.
Conclusion: Emergency stent grafting of RIIAA is feasible and safe with good midterm outcome. (J Vasc Surg 2010;52:
1159-63.)Isolated iliac artery aneurysms (IIAA) in the absence of
abdominal aortic aneurysm (AAA) are a rare pathology,
found in 0.03% of the population in autopsy studies1 and
accounting for 0.4% to 1.9% of all arterial aneurysms.2 The
most feared complication of an IAA is rupture, with a
perioperative mortality up to 60% when managed by open
repair (OR).2
Transluminal stent grafting has rapidly evolved as an
alternative to OR for elective repair of IIAA and has proven
short-term benefits compared with OR.3,4 Inherent advan-
tages of the endovascular technique in ruptured IAAA
(RIIAA) are the possibility of avoiding general anesthesia5
and the minimization of invasiveness in hemodynamic un-
stable patients. Therefore, endovascular management of
RIIAA seems a good alternative to OR. In this study, we
describe the clinical and morphologic performance of en-
dovascular management in patients with RIIAA in a single
center at midterm follow-up.
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This retrospective study was approved by our Institu-
tional Review Board. The study included all consecutive
patients who underwent endovascular repair of RIIAA at
our institution between April 2001 and December 2009.
Data from all patients were retrieved from our clinical
information system according to International Classifica-
tion of Disease (ICD) codes and retrospectively analyzed.
IIAA were defined as single or multiple aneurysms located
within the common, internal, or external iliac arteries. The
study excluded symptomatic, nonruptured IAAs and pa-
tients with coexisting AAAs (30 mm maximal diameter)
as well as patients with previous surgical AAA repair. Patient
characteristics, comorbidities, and symptoms before and at
presentation were reviewed.
A preinterventional computed tomography angiogra-
phy (CTA) with intravenous contrast was used in all pa-
tients to assess RIIAA location and diameter. Patients were
classified as having contained retroperitoneal rupture, free
intraperitoneal rupture, or fistula with any intra-abdominal
organ. If needed, multiplanar 2-dimensional reconstruc-
tions were obtained for better evaluation of the aneurysmal
neck and access arterial anatomy. Aneurysms were classified
as type I or II according to Fahrni et al.6 Presence or
absence of intraperitoneal hemorrhage, renal displacement,
and contrast agent extravasation was recorded. An interdis-
ciplinary panel of interventional radiologists and vascular
surgeons used CTA results, morphology, and availability of
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suitable for endovascular repair. During the study period,
all patients with RIIAA were treated endovascularly.
The intervention was performed in an operating room
located next to the emergency CT scanner equipped with a
mobile C-arm fluoroscopy (Siremoblie; Siemens, Erlangen,
Germany) or a fully equipped angiography suite (Philips
Integris V5000, Eindhoven, The Netherlands). No intra-
vascular or percutaneous ultrasound imaging was used dur-
ing the interventions.
Recorded operative data included blood pressure, pulse
rate, need for vasoconstrictor medication, time delay from
hospital admission to operation, anesthetic technique, pro-
cedural time, vascular access technique, use of transfemoral
balloon occlusion, stent graft types, necessity for internal
iliac artery occlusion, and necessity of additional surgical
procedures. Infrarenal aortic balloon occlusion was per-
formed with a compliant balloon (Reliant Stent Graft Bal-
loon Catheter; Medtronic, Minneapolis, Minn) introduced
through a contralateral 12F-sheath (RCFW; Cook Medical
Inc, Bloomington, Ind). Limited unilateral stent grafting
of RIIAA was performed in cases with a sufficient neck
length (15 mm) of the proximal common iliac artery
(Excluder; W. L. Gore, Flagstaff, Ariz; Zenith; Cook Med-
ical Inc). Otherwise, bifurcated (Excluder or Zenith) or
aortouniiliac stent grafts (Zenith)were used. In the latter case,
a femorofemoral crossover bypass was performed after the
endovascular sealing of the rupture.
Internal iliac artery occlusion was achieved with an
ipsilateral approach. Coiling was performed with different
preshaped angiographic 5F catheters (Sim2; C2, Cook
Medical Inc; SOS Omni; AnigoDynamics Inc, Queens-
bury, NY), depending on anatomy and operator choice,
and 0.035-inch coils (Inconel-MReye; Cook Medical Inc)
or Amplatzer occluder plugs (AGA Medical Corp, Ply-
mouth, Minn). Embolization was performed immediately
before the stent graft deployment. The embolization was
restricted to the main trunk in nonaneurysmal internal iliac
arteries; in the other cases, sequential embolization of the
anterior and posterior division was performed.
Postinterventional anticoagulation was started 6 hours
after the intervention with a prophylactic dose of intrave-
nous heparin, usually 10,000 IE/24 hours in continuous
infusion, if the postinterventional CTA showed no signs of
further bleeding.
Details of the hospital course were reviewed, including
length of stay in the intensive care unit and total hospital
length of stay. Early and late postoperative complications
were graded as mild (spontaneous resolution, no prolonga-
tion of hospital stay, no permanent impairment), moderate
(need for significant intervention, prolongation of hospital
stay 24 hours, possible minor permanent disability), and
severe (major surgical or medical intervention, usually ac-
companied by prolonged or permanent disability and pos-
sible death) according to Chaikof et al.7 Operative death
was defined as death 30 days after the intervention re-
gardless of its cause; all other deaths were considered as late
deaths.Patients underwent CTA immediately after completion
of the procedure, then at 3, 6, and 12months, and annually
thereafter. These examinations were reviewed for size
changes of RIIAA as well as for postinterventional compli-
cations such as endoleaks, limb occlusions, stent graft kinks,
or migrations. A short-axis IIAA diameter change of 5
mm was defined as significant. According to the time of
appearance, endoleaks were classified as primary or second-
ary. Primary endoleaks are diagnosed 30-day periopera-
tive period, whereas secondary endoleaks appear in ex-
cluded aneurysms 30-day perioperative period.7 Leaks
seen in the immediate postinterventional CTA in our series
were classified as primary; all others were classified as sec-
ondary. Further classification was done according to their
cause.7
RESULTS
Patients. From April 2001 to December 2009, 11
consecutive patients (10 men; 1 woman), with a mean age
of 73 years, underwent endovascular repair of RIIAA.
During the same period, 204 patients with ruptured AAAs
presented at our institution. Six patients with RIIAA were
announced for treatment after having a CTA in a referring
hospital, whereas the remaining five presented in our emer-
gency department with abdominal pain. All patients that
were announced for the treatment of RIIAA were accepted
for hospital admission, and no patient was treated with a
primarily open repair or conservatively.Median surgical risk
was 4, according to the American Society of Anesthesiolo-
gists classification.8 Patient characteristics are summarized
in the Table. All patients had symptoms for at 1.5 hours
(range, 1.5-100 hours; mean, 24 hours).
Preinterventional imaging. Six patients underwent a
CTA in a referring hospital, whereas the remaining five
underwent the CTA in our hospital. Five patients had a
ruptured isolated common IAA, three a common IAA
extending into the internal iliac artery, and three an isolated
internal IAA. Three of the patients had other nonruptured
Table. Patient demographics and significant
comorbidities
Variable Value
Total patients, No. (%) 11 (100)
Age, mean (range) y 73 (59-88)
Male, No. (%) 10 (91)
Comorbidities, No. (%)
Coronary artery disease 2 (18)
Hypertension 9 (90)
Hyperlipidemia 2 (18)
Diabetes 1 (9)
Renal insufficiencya 3 (27)
COPD 2 (18)
History of smoking 4 (36)
ASA class, median (range)8 4 (3-5)
ASA, American Society of Anesthesiology; COPD, chronic obstructive
pulmonary disease.
aGlomerular filtration rate 60 mL/min/1.73 m2.IAAs: One patient had an additional isolated common iliac
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aneurysm extending into the internal iliac artery. The mean
maximal axial preoperative diameter of the RIIAA was 69.1
mm. Three patients had a contained retroperitoneal rup-
ture, eight had a free rupture with intra-abdominal hemor-
rhage, and six patients with free rupture showed extravasa-
tion of contrast at CTA. There was no patient with a fistula
to any intra-abdominal organ. Renal displacement was
recorded in eight patients.
There were four Ia, four Ib, five IIb, and one IIa type
RIIAAs according to Fahrni et al.6 In three patients with a
ruptured common IAAs extending in the internal iliac
artery, the common and the internal iliac aneurysm were
classified separately because this entity does not exist in the
classification according to Fahrni et al.
Operative data. At presentation at the emergency de-
partment, the mean systolic blood pressure was 112 mm
Hg (range, 80-135 mm Hg) and the mean pulse rate was
94 beats/min (range, 53-130 beats/min). Thirty-six per-
cent of the patients required vasopressor medication to
maintain the blood pressure. Whenever possible, vasopres-
sors were stopped and fluid administration was restricted
according to a protocol of hypotensive hemostasis.9
Mean delay from admission to arterial access was 78.5
minutes (range, 45-100 minutes). Mean delay from admis-
sion to arterial access in the six patients with known RIIAA
and announced to treatment was 77 minutes. Seven pa-
tients (64%) underwent the intervention under local anes-
thesia (about half of which required an additional intrave-
nous analgesia and sedation medication). The intervention
in two patients (18%) was started under local anesthesia and
later on switched to general anesthesia. The remaining two
patients (18%) underwent the entire intervention under
general anesthesia.
Completely percutaneous vascular access was obtained
in six patients (55%), two patients (18%) required bilateral
open common femoral artery exposure,10 and access in the
remaining 3 patients (27%) was one-sided open and one-
sided percutaneous. Four patients (36%) were hemodynam-
ically stabilizedwith endovascular placement of a transfemoral
abdominal aortic occlusionballoon at the beginningor during
the intervention.
All patients required unilateral occlusion of the internal
iliac artery. Coiling of the main trunk was performed in five
patients (45%), separate coiling of the anterior and poste-
rior division occurred in five patients (45%), and occlusion
of the main trunk with an Amplatzer occluder plug was
done in one patient (10%).
Three patients received a bifurcated stent graft, one
patient an aortouniiliac stent graft, and seven received a
total of nine unilateral tube stent grafts (2 inverted Zenith
iliac extenders11 and 7 Excluder contralateral iliac limb
devices). Additional surgical procedures included a femo-
rofemoral crossover bypass in the patient with the aorto-
uniiliac stent graft. Laparotomy and open abdomen treat-
ment due to an abdominal compartment syndrome was
necessary in three patients, which all presented with freeintraperitoneal rupture and contrast extravasation on CTA
and required vasopressor medication and mass transfusion
during and after the intervention. In all patients, a biologic
xenopericard patch (Supple Peri-guard Synovis Surgical
Innovations, St. Paul, Minn) was sutured on the rupture
site to avoid secondary hemorrhage after decompression.
An internal-external iliac artery bypass was completed in
one patient, and the internal iliac artery in one patient was
oversewed after showing a high volume type II endoleak in
the final angiography due to insufficient coil embolization
of the internal iliac artery.
Arterial access closure was achieved with the Perclose
technique in 3 patients who had completely percutaneous
access (Perclose; Abbott Vascular Devices, Redwood City,
Calif), by surgical closure in 2, manual compression and
surgical closure in 3, and only by manual compression in
the remaining 3 patients. The mean procedural time was
150 minutes (range, 45-380 minutes).
Early and late complications. The median intensive
care unit stay was 2 days; the median total hospital stay was
13 days. Two patients died perioperatively: one died of
disseminated intravascular coagulation disorder the day
after the intervention, and the other died of sudden cardiac
death 15 days after the intervention. No autopsy was per-
formed in either patient. There were no late deaths during
the follow-up period.
There were three mild early postoperative complica-
tions: one inguinal wound infection, one aspiration during
intubation, and one macrohematuria after bladder cathe-
terization. There was no rerupture or need for open surgi-
cal conversion during the follow-up period. One patient
needed an additional stent graft insertion for a type Ib
endoleak after 68 months.
Postinterventional imaging. All but two patients un-
derwent CTA immediately after the initial intervention.
The CTA in one patient was done after 12 hours due to
logistic problems, and the other one needed immediate
on-table conversion to open surgery due to abdominal
compartment syndrome and an angiographically high-
volume type II endoleak due to insufficient coil emboliza-
tion of the internal iliac artery. During the postinterven-
tional period studied, an overall of 37 CT scans were
performed. Each patient was scanned an average of three
times, within a mean observation time of 23 months
(range, 0-69 months).
The last measured maximal axial diameter of the aneu-
rysm sac was unchanged in four patients (44%) or had
decreased (5 mm) in the other five (56%). There was no
patient with aneurysm sac growth. A type Ib endoleak
developed in one patient after 68 months and was treated
with an additional stent graft insertion. There was no
patient with significant stent graft kinking or limb occlusion
needing any secondary intervention. Three patients had a
primary type II endoleak and one patient a secondary type
II endoleak, as well as the mentioned secondary type Ib
endoleak during follow-up.
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Emergency open repair of RIIAA still has an estimated
operative mortality of 28%, with a wide range from 0% to
61%.2 In this situation, endovascular stent grafting is prom-
ising. The aneurysm can be approached endoluminally by a
remote access through a femoral artery, thus avoiding
laparotomy. Another benefit of “no laparotomy access” is
avoidance of releasing the unreleased retroperitoneal hema-
toma impeding further blood loss due to the tamponading
effect. The endoluminal intervention can be performed
under local anesthesia,5 and the abdominal wall tone and
regulatory function of the sympathetic system are not af-
fected. These advantages of endovascular repair appear
obvious. The 30-day mortality was 18% in our study, which
is lower than the reported mortality of open treatment and
is in the same range of 30-day mortality of endovascularly
treated ruptured infrarenal aortic aneurysms.12 This, even
though three of our patients sustained abdominal compart-
ment syndrome, which increases the mortality risk, even
when open abdomen treatment is initiated early.13
Despite all these potential advantages, endovascular
stent grafting has its drawbacks. Endovascular emboliza-
tion of the internal iliac artery, especially in cases of rupture,
is sometimes technically challenging or even impossible due
to the hemodynamic instability of the patient, changed
anatomic configuration due to the expanding hematoma,
and the need of expeditious, stable solutions. In one of our
patients, the coiling of the internal iliac artery was insuffi-
cient to stop the retrograde perfusion of the aneurysm sac
intraoperatively, and due to further bleeding through this
type II endoleak, conversion to open surgery was necessary.
In cases with difficulty or impossibility to embolize the
internal iliac artery, contralateral aortouniiliac stent grafting
with occlusion of the ipsilateral ruptured common iliac
artery or early conversion to open surgery with temporary
aortic balloon occlusion would be possible alternatives.
The limited durability assessments of stent grafts and
the rate of incompletely excluded aneurysmal sacs remain
unsolved issues. Therefore, lifelong imaging follow-up has
been advocated after elective endoluminal repair of aneu-
rysms. CTA is still regarded as a widely available standard
diagnostic modality for surveillance of endovascularly
treated IIAA because it provides useful information on the
evolution of the aneurysm, the patency of the conduit, the
presence of endoleaks, and extent of the stent graft integ-
rity.14 All consecutive patients with endovascular repair of
RIIAA were monitored using the same CTA interval and
protocol as for nonruptured IIAA, with exception of the
immediate postinterventional CTA.
Endoleaks, occurring in up to a quarter of IIAA elec-
tively treated with self-expanding devices, may present a
persisting risk of rupture.15 Atmidterm follow-up, freedom
from endoleak was present in two-thirds of our patients.
The single type Ib endoleak was treated successfully by
transluminal stent graft extension.
Chronic (primary and secondary) type II endoleaks due
to incompletely embolized internal iliac arteries were foundin 33% of our patients. This is within the same range as for
nonruptured IIAA using a variety of bifurcated commer-
cially devices.15 That no aneurysm rerupture occurred at
midterm underlines the currently accepted opinion that
type II endoleaks in most patients are innocuous and only
need treatment if associated with aneurysm growth.
Overall, a reduction of aneurysm diameter occurred in
56% but remained unchanged in 44%. For comparison, a
study of nonruptured IIAA treated with stent grafts found
the aneurysm sac remained stable in 28% and decreased in
72%.4 In another study, also with a variety of stent grafts
and using the same definition of growth as we did, 67% of
the nonruptured IIAA had shrunken at a mean follow-up of
2 years.15 Therefore, the outcome of the aneurysm diame-
ter of ruptured and nonruptured aneurysms seems to be
similar after endovascular repair.
Our study is subject to some limitations. The patients
have been treated during a period of8 years. During this
time, CT technology has evolved and thus scanner gener-
ations were not the same for all patients. For this reason,
detection of small endoleaks might have been restricted.
The stent grafts used were from two different manufactur-
ers, and stent graft technology has also progressed in recent
years. Finally, comparison of the midterm outcome of
ruptured aneurysms with published series of nonruptured
aneurysms treated with the same technique is hampered by
the different magnitude of the sample size. Obviously, this
reflects the incidence of the two entities.
CONCLUSIONS
Our results indicate that, the 30-day mortality of endo-
vascular treatment of ruptured isolated iliac artery aneu-
rysm is in the lower range of the published series of these
aneurysms treated by open repair. After discharge of the
patient, the outcome of endovascular repair of ruptured
isolated iliac artery aneurysm is similar to the published
series of nonruptured isolated iliac artery aneurysm repaired
endovascularly.
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